1. Home
  2. Stocks
  3. Morepenlab Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Morepen Laboratories Share Price

    Small Cap
    ₹88.94
    -3.07 (-3.34%)
    18 September, 2024 02:46 BSE: 500288 NSE: MOREPENLAB ISIN: INE083A01026

    Start SIP in Morepen Laboratories

    Start SIP

    Morepen Laboratories Performance

    Day Range

    • Low 88
    • High 92
    ₹ 88

    52 Week Range

    • Low 31
    • High 101
    ₹ 88
    • Open Price92
    • Previous Close92
    • Volume9517358

    Morepen Laboratories Chart

    • Over 1 Month + 46.16%
    • Over 3 Month + 58.48%
    • Over 6 Month + 111.76%
    • Over 1 Year + 136.54%

    Morepen Laboratories Key Statistics

    P/E Ratio 41.4
    PEG Ratio 0.3
    Market Cap Cr
    Price to Book Ratio 5.8
    EPS 2
    Dividend 0
    Relative Strength Index 61.54
    Money Flow Index 73.44
    MACD Signal 7.6
    Average True Range 5.3

    Morepen Laboratories Investment Rating

    • Master Rating:

    • Morepen Laboratories has an operating revenue of Rs. 1,744.61 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 8% is okay, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 37% and 75% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Morepen Laboratories Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 386393395381369337
    Operating Expenses Qtr Cr 337336344351344321
    Operating Profit Qtr Cr 495651302515
    Depreciation Qtr Cr 476555
    Interest Qtr Cr 112001
    Tax Qtr Cr 121312763
    Net Profit Qtr Cr 354035201610
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,5501,345
    Operating Expenses Annual Cr 1,3761,262
    Operating Profit Annual in Cr 16277
    Depreciation Cr 2218
    Interest Annual Cr 42
    Tax Annual Cr 3817
    Net Profit Annual Cr 11146
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 77-102
    Cash from Investing Activity Annual Cr -84-36
    Cash from Financing Annual Activity Cr 0144
    Net Cash Flow Annual Cr -66
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 889780
    Fixed Assets Annual Cr 241188
    Total Non Current Assets Annual Cr 436375
    Total Current Assets Annual Cr 843731
    Total Assets Annual Cr 1,2791,106
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 1715
    ROE Annual % 126
    ROCE Annual % 168
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 116
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 455423445422401364
    Operating Expenses Qtr Cr 404375394388375348
    Operating Profit Qtr Cr 524851342616
    Depreciation Qtr Cr 6108887
    Interest Qtr Cr 112001
    Tax Qtr Cr 121312763
    Net Profit Qtr Cr 36283221158
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,7041,424
    Operating Expenses Annual Cr 1,5321,338
    Operating Profit Annual in Cr 15980
    Depreciation Cr 3328
    Interest Annual Cr 42
    Tax Annual Cr 3917
    Net Profit Annual Cr 9639
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 73-91
    Cash from Investing Activity Annual Cr -83-47
    Cash from Financing Annual Activity Cr 5144
    Net Cash Flow Annual Cr -56
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 847753
    Fixed Assets Annual Cr 257210
    Total Non Current Assets Annual Cr 404354
    Total Current Assets Annual Cr 889756
    Total Assets Annual Cr 1,2931,110
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 1715
    ROE Annual % 115
    ROCE Annual % 167
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 106
    Invest in Morepen Laboratories

    Morepen Laboratories Technicals

    EMA & SMA

    Current Price
    ₹88.94
    -3.07 (-3.34%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹85.25
    • 50 Day
    • ₹73.75
    • 100 Day
    • ₹64.58
    • 200 Day
    • ₹55.95
    • 20 Day
    • ₹85.89
    • 50 Day
    • ₹69.63
    • 100 Day
    • ₹60.00
    • 200 Day
    • ₹53.87

    Morepen Laboratories Resistance and Support

    PIVOT
    ₹89.82
    Resistance
    First Resistance 91.48
    Second Resistance 94.01
    Third Resistance 95.68
    RSI 61.54
    MFI 73.44
    MACD Single Line 7.60
    MACD 7.19
    Support
    First Support 87.28
    Second Support 85.61
    Third Supoort 83.08

    Morepen Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 10,166,975 414,100,892 40.73
    Week 14,397,826 467,209,460 32.45
    1 Month 42,024,495 1,086,753,451 25.86
    6 Month 13,917,354 417,798,954 30.02

    Morepen Laboratories Result Highlights

    Morepen Laboratories Synopsis

    NSE-Medical-Diversified

    Morepen Labs.Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1338.88 Cr. and Equity Capital is Rs. 102.23 Cr. for the Year ended 31/03/2023. Morepen Laboratories Ltd. is a Public Limited Listed company incorporated on 01/12/1984 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24231HP1984PLC006028 and registration number is 006028.
    Market Cap 5,042
    Sales 1,554
    Shares in Float 35.07
    No of funds 46
    Yield
    Book Value 5.29
    U/D Vol ratio 3.5
    LTDebt / Equity
    Alpha 0.21
    Beta 1.68

    Morepen Laboratories Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 38.22%38.22%38.22%38.22%
    Mutual Funds 0.05%
    Insurance Companies 1.01%1.01%1.01%1.02%
    Foreign Portfolio Investors 1.67%1.85%2.11%1.29%
    Financial Institutions/ Banks 0.21%0.92%0.22%0.98%
    Individual Investors 45.22%45.03%44.45%45.56%
    Others 13.67%12.97%13.99%12.88%

    Morepen Laboratories Management

    Name Designation
    Mr. Sushil Suri Chairman & Managing Director
    Mr. Sanjay Suri Whole Time Director
    Mr. Manoj Joshi Independent Director
    Mr. Bhupender Raj Wadhwa Independent Director
    Mr. Sukhcharan Singh Independent Director
    Mr. Praveen Kumar Dutt Independent Director
    Mrs. Savita Independent Director

    Morepen Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Morepen Laboratories Corporate Action

    Date Purpose Remarks
    2024-08-12 Quarterly Results
    2024-05-21 Audited Results
    2024-01-31 Quarterly Results
    2023-11-02 Quarterly Results
    2023-08-05 Quarterly Results

    Morepen Laboratories MF Shareholding

    Name Amount(cr)

    Morepen Laboratories FAQs

    What is Share Price of Morepen Laboratories ?

    Morepen Laboratories share price is ₹88 As on 18 September, 2024 | 02:32

    What is the Market Cap of Morepen Laboratories ?

    The Market Cap of Morepen Laboratories is ₹4873.5 Cr As on 18 September, 2024 | 02:32

    What is the P/E ratio of Morepen Laboratories ?

    The P/E ratio of Morepen Laboratories is 41.4 As on 18 September, 2024 | 02:32

    What is the PB ratio of Morepen Laboratories ?

    The PB ratio of Morepen Laboratories is 5.8 As on 18 September, 2024 | 02:32

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.